山东前沿医疗器械股份有限公司 manufactures medical ozone therapy devices and other medical equipment, self-described as a high-tech enterprise.

山东前沿医疗器械股份有限公司

Blue Sail Medical Co.,Ltd. manufactures and sells health protection gloves in China and internationally. The company offers disposable medical, latex, nitrile, PVC, TPE, and household gloves that are used for medical inspection and protection, food processing, electronics industry, etc. It is also involved in the research, development, production, and sales of cardiac stents and interventional cardiac surgery related equipment products. The company was formerly known as Shandong Blue Sail Plastic & Rubber Co., Ltd. and changed its name to Blue Sail Medical Co.,Ltd. in July 2014. Blue Sail Medical Co.,Ltd. was founded in 2002 and is based in Zibo, China.

Blue Sail Medical Co.,Ltd.

Dongfeng Motor Group Company Limited manufactures and sells commercial vehicles, passenger vehicles, and engines and parts in the People's Republic of China. It operates in four segments: Commercial Vehicles, Passenger Vehicles, Financing Service, and Corporate and Others. It provides commercial vehicles, including trucks and buses; passenger vehicles comprising basic passenger cars, MPVs, and SUVs; electric vehicles, off-road vehicles, and special commercial vehicles; and other automobile related products. The company also provides financial services. In addition, it markets and sells automobiles. The company is based in Wuhan, the People's Republic of China. Dongfeng Motor Group Company Limited is a subsidiary of Dongfeng Motor Corporation.

Dongfeng Motor Group Company Limited

深圳开立生物医疗科技股份有限公司 specializes in the research and manufacturing of medical devices, covering areas such as ultrasound medical imaging, endoscopy, minimally invasive surgery, and cardiovascular intervention.

Metric
Company Name	山东前沿医疗器械股份有限公司	Blue Sail Medical Co.,Ltd.	Dongfeng Motor Group Company Limited	深圳开立生物医疗科技股份有限公司
Symbol		2.38K	489
MSH ID	CN:COM:ZAMT	CN:BLUESAIL	CN:COM:DFMG	CN:COM:SONOSCAPE
Market	PRIVATE	STOCKS	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Consumer Cyclical	Healthcare & Health Services
Industry	Medical Devices	Medical - Instruments & Supplies	Auto - Manufacturers	Medical Devices
Country	CN	CN	CN	CN
Stage
Employee Count		8.09K	112.71K
Website	zamt.com.cn	bluesail.cn	dfmg.com.cn	sonoscape.com.cn
LinkedIn
Founders

Metric
Market Cap	615.22M	2.49B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	679.41M	13.69B
Revenue (LTM)
Revenue (NTM)
Gross Profit	83.57M	1.16B
EBITDA	5.14M	-888.03M
Operating Income	-64.81M	-1.45B
Net Income	-78.37M	-551.02M
EPS	-0.08	-0.06
Diluted EPS	-0.08	-0.06
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.14	0.08
Operating Profit Margin	-0.09	-0.10
EBITDA Margin	0.01	-0.06
Net Profit Margin	-0.09	0.06
Return on Equity	-0.05	0.04
Return on Assets	-0.03	0.02
Return on Capital Employed	-0.04	-0.05

COM

CN:COM:ZAMT

山东前沿医疗器械股份有限公司

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-7.61	2.39
P/B Ratio	0.45	0.16
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.23	0.30
EV Multiple	-6.25	-5.41

Metric
Days Sales Outstanding	83.23
Days Payables Outstanding	39.04	180.28
Days Inventory Outstanding	90.99	57.15
Operating Cycle	174.03	137.88
Cash Conversion Cycle	134.99	-64.11
Asset Turnover	0.35	0.32

Metric
Operating Cash Flow	-10.05M
Free Cash Flow	-116.80M
Cash Flow to Debt	-0.02	0.25
Operating Cash Flow/Sales	-0.01	0.15
Free Cash Flow Yield	-0.23	-0.07

Metric
Cash & Equivalents	176.82M	10.93B
Accounts Receivable	-34.14M
Inventory	145.41M	1.96B
Goodwill	534.24M	435.05M
Debt to Capitalization	0.30	0.29
Debt to Assets	0.23	0.17
Current Ratio	1.22	1.41
Quick Ratio	1.15	1.24

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.07
SG&A to Revenue	0.02	0.06